Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2011

View Archived Issues

Eribulin prolongs survival of patients with breast cancer in EMBRACE trial

HIV vaccine MVA-B is safe and appears immunogenic in healthy subjects

Vadimezan exhibits therapeutic and prophylactic antiviral effects in preclinical study

Threshold Pharma identifies new 14-aminocamptothecins with potential as cancer therapeutics

Overexpression of fatty acid synthase correlates with high-risk GIST

Basilea Pharma patents new inhibitors of cAMP-specific 3',5'-cyclic phosphodiesterase 4

Anacor Pharma synthesizes new boron-containing antiprotozoal agents

Mitsubishi Tanabe and sanofi-aventis present new GSK-3 beta inhibitors

Phylogica and University of Cambridge to form spin-off Phenomica

New FGFR-2 activators reported by sanofi-aventis

Fresenius Biotech receives German approval to use ATG-Fresenius S in stem cell transplantation

Aeterna Zentaris and Yakult Honsha enter exclusive agreement for perifosine in Japan

Combination of Chk1 inhibitor and gemcitabine shows promise in model of colon cancer

Salix Pharma receives complete response letter for Xifaxan sNDA for non-constipation-predominant IBS

Xeplion is approved in Europe for schizophrenia

FDA removes clinical hold on AT-2220 for Pompe's disease

Global Health Ventures completes trials comparing lX-Excite to Viagra

Pfizer's axitinib receives European orphan drug status in renal cell carcinoma

Fibrocell Science and UCLA join to advance dermal fibroblast cell therapy

Biovest's BiovaxID receives E.U. orphan drug status in mantle cell lymphoma

GSK and HGS receive FDA approval for new lupus treatment Benlysta

Phase II trial of PD-0332991 in advanced NSCLC is under way

Auxilium Pharma reaches target enrollment in phase III Xiaflex trials in Peyronie's disease

Repligen's RG-2417 does not significantly improve symptoms of depression in phase IIb trial

Tyroxenex's X-82 enters phase I trial in advanced solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...